Novo Nordisk CEO to face off with Bernie Sanders over 1,300% Ozempic markup in U.S.

Novo’s Danish CEO Lars Fruergaard Jørgensen will face the U.S. Senate in September to defend Wegovy’s and Ozempic’s eye-watering prices.